Evaluation of Hair Regrowth After Minoxidil and Dutasteride Tattooing in Men with Androgenetic Alopecia
May 2023
in “
JAAD international
”
Studysummary This study evaluated the clinical outcomes of using tattoo equipment to deliver a combination of minoxidil and dutasteride directly to the scalp over three sessions for treating male androgenetic alopecia, but results are not reported in the abstract.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study "Evaluation of Hair Regrowth after Minoxidil and Dutasteride Tattooing in Men with Androgenetic Alopecia" conducted a retrospective analysis of 15 male patients who underwent three monthly sessions of minoxidil-dutasteride tattooing (MDT) from 2016 to 2020 due to a lack of response to topical minoxidil and oral 5-α-reductase inhibitors. The primary outcome was defined as achieving >10% top scalp area regrowth (TSAR), calculated based on the difference in the top-quadrant Severity of Alopecia Tool (SALT) scores. The results showed that 53% of the patients achieved a mean TSAR of >10%, and 27% achieved a mean TSAR of >20%. Patients with vellus hair at the baseline had a 63% success rate compared to 22% in those with no vellus hair. The study concluded that MDT could be a potential treatment for male AGA, especially for those with vellus hair at the baseline.
